CXCL10 and cystic fibrosis: Specifically, it was found that IP-10 and MCP-1 are increased in IPF patients, while MIG is increased in across all 3 end-stage groups, and MIF is specifically increased in CF patients when each were compared to lung donor and healthy volunteer control plasma (Figure 7A-D).